Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fornarini, B.
Right arrow Articles by Iacobelli, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fornarini, B.
Right arrow Articles by Iacobelli, S.
Related Collections
Right arrow Neoplasia
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 November 2000, Vol. 96, No. 9, pp. 3282-3285

BRIEF REPORT

Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo

Bruna Fornarini, Consuelo D'Ambrosio, Clara Natoli, Nicola Tinari, Vittorio Silingardi, and Stefano Iacobelli

From the Department of Oncology and Neurosciences, University G. D'Annunzio Medical School, Chieti, Italy; and the Department of Medical, Oncological and Radiological Sciences, University of Modena and Reggio Emilia Medical School, Modena, Italy.

A cell-adhesive protein of the human serum, 90K binds galactin-3, beta 1-integrins, collagens, and fibronectin, and it is of importance in cell-cell and cell-extracellular matrix adhesion. Serum 90K levels in 137 patients with lymphoma were measured by enzyme-linked immunosorbent assay. Compared with healthy controls, pretreatment serum 90K levels in patients with lymphoma were elevated (P < .001). Of 97 patients who showed objective response to treatment, 20 (21%) had pretreatment 90K levels above the normal cutoff compared with 17 (53%) of 32 patients who did not respond (P = .002). When used as a plastic-immobilized substrate, 90K caused a significant reduction in chemotherapy-induced apoptosis of Jurkat T lymphoma cells. This finding could explain the lack of response in lymphoma patients with high 90K serum levels.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
G. Sardana, J. Marshall, and E. P. Diamandis
Discovery of Candidate Tumor Markers for Prostate Cancer via Proteomic Analysis of Cell Culture-Conditioned Medium
Clin. Chem., March 1, 2007; 53(3): 429 - 437.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Grassadonia, N. Tinari, B. Fiorentino, K. Suzuki, M. Nakazato, M. De Tursi, C. Giuliani, G. Napolitano, D. S. Singer, S. Iacobelli, et al.
The 90K Protein Increases Major Histocompatibility Complex Class I Expression and Is Regulated by Hormones, {gamma}-Interferon, and Double-Strand Polynucleotides
Endocrinology, October 1, 2004; 145(10): 4728 - 4736.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. J. Terol, M. Tormo, J. A. Martinez-Climent, I. Marugan, I. Benet, A. Ferrandez, A. Teruel, R. Ferrer, and J. Garcia-Conde
Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome
Ann. Onc., March 1, 2003; 14(3): 467 - 474.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020